Table 1.

Plasma levels of TLR9 activity, neutrophil activation markers and pro-inflammatory cytokine IL-8 in patients with preterm and term preeclampsia.

Neutrophil markers	15 weeks (Preterm N = 19)	15 weeks (Term N = 38)	P Value	20 weeks (Preterm N = 19)	20 weeks (Term N = 37)	P Value	TOD (Preterm N = 6)	TOD (Term N = 16)	P Value
TLR9 Signal	0.31 ± 0.05	0.27 ± 0.03	0.66	0.30 ± 0.06	0.29 ± 0.03	0.41	0.37 ± 0.03	0.39 ± 0.04	0.713
Calprotectin (ng/ml)	1043.15 ng/ml ± 126.19	1645.66 ng/ml ± 187.30	0.16	886.99 ± ng/ml 245.48	1167.96 ng/ml ± 77.80	0.57	1878.35 ng/ml ± 424.90	2055.57 ng/ml ± 170.62	0.77
MPO (ng/ml)	4.42 ng/ml [1.77–10.25]	6.58 ng/ml [2.11–9.70]	0.56	4.55 ng/ml [2.48–8.74]	6.15 ng/ml [2.96–21.46]	0.84	8.59 ng/ml [4.72–11.87]	8.33 ng/ml [5.67–14.78]	0.43
MMP8 (pg/ml)	1138.41 pg/ml ± 149.24	989.38 pg/ml ± 113.31	0.25	1097.48 pg/ml ± 108.58	1098.46 pg/ml ± 88.69	0.97	1775.73 pg/ml ± 466.30	1263.75 pg/ml ± 182.92	0.12
IL-8 (pg/ml)	32.09 pg/ml [7.40–192.91]	8.12 pg/ml [2.19–18.25]	0.17	22.92 pg/ml [4.76–188.69]	12.67 pg/ml [2.11–18.23]	0.32	24.63 pg/ml [2.68–47.59]	24.63 pg/ml [9.78–75.14]	0.81

Data is presented as mean ± SEM and median (25–75 percentiles) where applicable.